<DOC>
	<DOC>NCT00943852</DOC>
	<brief_summary>This study will qualify a functional model that can measure central blood pressure and vascular compliance effects through noninvasive means.</brief_summary>
	<brief_title>The Effect of Losartan and Losartan Plus Isosorbide Mononitrate on Central Blood Pressure Measurements (0954-317)</brief_title>
	<detailed_description />
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Patient is in good health with the exception of mild to moderate hypertension Patient is willing to comply with the study restrictions Patient does not smoke Patient has a history of any illness that might confound the results of the study or make participation in the study unsafe Patient is taking a prescription medication that is contraindicated for use with COZAAR速 or IMDUR速 Patient has a condition for which there is a warning, contraindication, or precaution against the use of COZAAR速 or IMDUR速</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>